Pushback on narrow networks likely the reason behind administration's new tweak
By Julie Miller
Federal officials are allowing enrollees who signed up on healthcare.gov to switch their plans through March 31, according to the Washington Post. Reportedly, a memo was sent to insurers notifying them of the change.
“Health plans are focused on ensuring consumers have the support they need to choose the coverage option that is right for them,” says Clare Krusing, spokesperson for America’s Health Insurance Plans (AHIP).
The change is one that plans are generally supportive of because it’s in their best interest to make sure members enroll in the right policy. New members and potential members are overwhelming plans’ call centers with questions surrounding open enrollment, while at the same time narrow networks are under fire from federal officials who suggest that next year's plans will be reviewed for network adequacy.
Undoubtedly allowing consumers to switch plans is a response to complaints from members who signed up for a plan and found out later that their preferred providers are not in-network. Previously, healthcare.gov visitors could withdraw an application and start over, but they weren’t able to disenroll after choosing a plan.
According to AHIP, plans will have to accommodate the switches manually because the new exchange functionality isn't ready yet.
However, a spokesperson for Covered California-a state-operated exchange that has performed relatively well during open enrollment-says its platform has always offered the ability for consumers to switch plans.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
New PTSD Treatment Shows Promise with Brexpiprazole, Sertraline Combination
December 24th 2024Currently, the only medications approved by the FDA for PTSD are the selective serotonin reuptake inhibitors (SSRIs) sertraline and paroxetine. However, these medications don’t work for everyone.
Read More